Currency: AUD
Period
H1 FY2024 Earnings
--
-0.07
-17.20M
Strong Buy
May 15, 2024
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Clarity Pharmaceuticals Ltd: Half Yearly Report and Accounts
Feb 28 23:06 ET
Clarity Pharmaceuticals Ltd: Appendix 4D
Feb 28 22:57 ET
Clarity Pharmaceuticals Ltd: Annual Report to shareholders
Sep 28, 2023 20:07 ET
Clarity Pharmaceuticals Ltd: Preliminary Final Report
Aug 23, 2023 23:29 ET
Read more
Updated: May 15, 2024
Buy
Hold
Underperform
Sell
No Data